Polycystic Ovary Syndrome (PCOS) - 5-10% of women 50% lower glutathione levels compared to women without PCOS 3-4x higher risk of preeclampsia 3x higher risk of gestational diabetes Critical concern: With 50% lower baseline glutathione, the "safe" dose is effectively cut in half IVF Conception - 2-5% of births (up to 6-8% in some countries) Women who conceive via IVF experience dramatic antioxidant depletion: 70% reduction in plasma antioxidant capacity 83% reduction in follicular fluid antioxidant capacity 50-100%+ increase in oxidative stress markers With over 5 million babies born via IVF globally, this represents a large high-risk population Gallbladder Dysfunction - 10% of pregnant women Up to 10% develop gallstones or biliary sludge Intrahepatic cholestasis: 0.4-10% of pregnancies CRITICAL: Fatal Outcomes Documented at Therapeutic Doses The first case of a pregnant woman with intrahepatic cholestasis who died from liver failure after taking THERAPEUTIC/NORMAL doses of acetaminophen was reported in 2022

No bad effects were reported
Some of these therapies include but are not limited to phosphate binders, vitamin K supplementation, sodium thiosulfate, etc
The purity of the neutrophil population was typically greater than 90%, as determined by morphological examination with Giemsa staining and flow cytometry, based on CD11b + (1:500, clone M1/70) and Ly6G + (1:500, clone 1A8) surface markers
Moreover, when used in synergy with other anti-aging treatments, it could potentially enhance their efficacy, providing comprehensive and optimal results
[PubMed: 9497326] 851